Robert Vander Stichele is a certified clinical pharmacologist, pharmaco-epidemiological researcher, and retired family physician in Ghent, Belgium. His interests include information on and use of medicines. He is member of the Special Interest Group on Drug Utilization in the International Society for Pharmaco-epidemiology (ISPE). He is a senior-researcher in the research alliance on ‘End-of-Life Care’, a consortium of the University of Ghent, Brussels, Amsterdam and Rotterdam. He is member of the Board of the International Society of Phthirapterists (ISOP), and of the European Society for the study of Patient Adherence and Compliance (ESPACOMP). He is founding member of the Board of the Belgian Centre for Evidence-Based -Medicine (CEBAM). Currently, he works as an expert in European projects for the European Institute for Innovation through Health Data (I-HD), and in Ramit, a spinoff of the Department of Medical Informatics of the University of Ghent. He has been appointed as work package leader for the UNICOM project on Identification of Medicinal Products, working on applications of the new ISO IDMP standards to clinical practice and medical clinical research. His publication list comprises over 180 scientific papers (referenced in Medline and Web of Science).
Please log into your account to view faculty contact details.
Senior Research Consultant European Institute of Innovation through Health Data (I-HD); Ghent University, Belgium
A recent paper (Vander Stichele et al. 2020) published in Vaccine highlighted the need for global monitoring of vaccine use (who was inoculated with which vaccine product, where and when) as well as its safety and effectiveness. HealthManagement.org asked the authors about the challenges of implementing such system in practice and possible measures to minimise the accompanying risks....
READ MORE
